Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 12/20 | 0.65 |
| ▸ | MGLL | Q99685 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.42 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.42 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25488248 | 0.93 | FAAH (0.76) | FAAHMGLLALDH1A1 | |
| SCHEMBL25488006 | 0.92 | FAAH (0.76) | FAAHMGLLALDH1A1PLA2G7ABHD6 | |
| SCHEMBL25829970 | 0.91 | FAAH (0.54) | FAAHMGLLALDH1A1 | |
| SCHEMBL25487850 | 0.83 | FAAH (0.63) | FAAHMGLL | |
| SCHEMBL25829817 | 0.81 | FAAH (0.65) | FAAHMGLLALDH1A1PLA2G7ABHD6 | |
| SCHEMBL25830556 | 0.81 | FAAH (0.56) | FAAHMGLLALDH1A1PLA2G7ABHD6 | |
| SCHEMBL25488236 | 0.80 | FAAH (0.54) | FAAHMGLLALDH1A1PLA2G7ABHD6 | |
| SCHEMBL30420360 | 0.79 | FAAH (1.00) | FAAHMGLLPLA2G7ABHD6 | |
| SCHEMBL20567315 | 0.79 | FAAH (1.00) | FAAHMGLLPLA2G7ABHD6 | |
| SCHEMBL25830106 | 0.79 | FAAH (0.67) | FAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | FAAH 33/4885MGLL 1/4885ALDH1A1 2448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.